Abiopharma

News list

Director Horning Sandra 🟡 adjusted position in 0 shares (1 derivative) of Moderna, Inc. (MRNA) Transaction Date: Apr 30, 2026 | Filing ID: 000075

Full text

News bot May 4, 2026, 9:40 p.m.
🔍 Horning Sandra (Director)

Company: Moderna, Inc. (MRNA)

Report Date: 2026-04-30
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 16,233
- Total shares sold: 16,233
Detailed Transactions and Holdings:
- Acquired 16,233 shares of Common Stock (Direct)
  Date: 2026-04-30 | Code: M | equity_swap_involved: 0 | shares_owned_after: 18,585.00 | transaction_form_type: 4 | Footnotes: F1, F1
- Sold 16,233 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-30 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F1, F2, F2
Footnotes:
- F1: Restricted stock units convert into common stock on a one-for-one basis.
- F2: The shares subject to this restricted stock unit award vested in full on April 30, 2026.